跳至主要内容
临床试验/EUCTR2010-022952-22-IT
EUCTR2010-022952-22-IT进行中(未招募)不适用

Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA) - NoVARA

AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA0 个研究点开始时间: 2010年12月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • patients with aged 18 years and 90 yearsa dmitted in hospital for acute coronary syndrome with persistente ST elevation and chest pain less than 12 hours
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • shock cardiogenic, chronic dialisis, pregnancy, allergy to N-acetylcysteine, inability to obtain informed consent

研究者

发起方
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA

相似试验